You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 121658


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 121658

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,791,122 Aug 1, 2030 Actelion UPTRAVI selexipag
9,284,280 Jun 25, 2030 Actelion UPTRAVI selexipag
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Drug Patent AR121658

Last updated: July 27, 2025


Introduction

The patent AR121658 pertains to a pharmaceutical invention within Argentina's intellectual property framework. Understanding its scope and claims is crucial for stakeholders evaluating patent validity, commercialization potential, and patent landscape positioning. This analysis provides an in-depth review of the patent’s scope, claims, and its contextual landscape within Argentina’s patent environment, emphasizing strategic insights for pharmaceutical companies, legal practitioners, and R&D entities.


Overview of Patent AR121658

Patent AR121658 was granted in Argentina, with a priority date likely preceding the grant, securing exclusive rights over a novel pharmaceutical invention. While detailed patent documentation is required for exhaustive analysis, typical patent scope and claims analysis relies on publicly available patent filings and legal databases.

Note: This assessment assumes AR121658 relates to a drug composition or process, common within pharmaceutical patents, though explicit details depend on patent documentation.


Scope of the Patent

Legal Scope:
The scope defines the legally enforceable boundaries of the patent rights in Argentina. It encompasses the invention as described and claimed, primarily covering specific chemical compounds, formulations, or methods for manufacturing.

Technical Scope:
The scope likely extends over:

  • Specific active pharmaceutical ingredients (APIs) or their derivatives.
  • Formulation techniques enhancing bioavailability or stability.
  • Manufacturing processes offering efficiency or purity improvements.
  • Usage indications for particular medical conditions.

Geographical Scope:
Limited to Argentina, unless international patent rights are referenced or the patent is part of broader multinational rights via filed applications in other jurisdictions.


Claims Analysis

The claims in AR121658 form the core of its patent protection. They delineate the precise aspects of the invention deemed novel and inventive by the patent office.

Types of Claims:

  • Independent Claims:
    Core claims establishing the fundamental invention, potentially covering a specific chemical compound, combination, or method.

  • Dependent Claims:
    Sub-claims that specify additional features, such as specific concentrations, process steps, or formulations, narrowing the scope.

Potential Claim Features:

  • Structural claims covering novel chemical entities with specific functional groups.
  • Method claims related to synthesis protocols.
  • Composition claims detailing ratios and excipients.

Claim Examination Considerations:

  • Novelty:
    The invention must differ from prior art, including previous patents, scientific literature, and public disclosures. Argentina’s patent office likely evaluated prior Argentine and global references.

  • Inventive Step:
    The claims should involve an inventive step, not obvious to skilled artisans in the pharmaceutical domain considering the state of art.

  • Broader vs. Narrow Claims:
    Broader claims may offer robust protection but risk invalidity if prior art exists; narrower claims are safer but provide limited scope.


Patent Landscape Context

Understanding AR121658’s place within the broader patent ecosystem involves analyzing:

1. Prior Art and Related Patents:
Argentina maintains an active patent environment with a significant number of pharmaceutical patents originating from local inventors and multinational corporations. The patent landscape around AR121658 likely includes:

  • Patent families covering similar compounds or formulations.
  • Overlapping claims with international patents filed under the Patent Cooperation Treaty (PCT) or regional patents in Latin America.

2. Competitive Patent Filings:
Analyzing filings by competitors helps assess how this patent fits into broader innovation strategies. If AR121658 overlaps with global patents, it could denote access or freedom-to-operate issues.

3. Patent Validity and Opposition:
Argentina’s patent office allows for oppositions or challenges during or post-grant. The strength of AR121658 depends on its defensibility against prior art challenges.

4. Patent Expiry and Lifecycle:
Patents typically last 20 years from the earliest priority date. Delineating expiration timelines informs commercial strategies post-licensing or patent expiry.


Strategic Implications for Stakeholders

  • For Innovators:
    Ensuring claims coverage aligns with current scientific knowledge avoids potential invalidation. Exploiting narrow claims increases ease of enforcement but limits scope.

  • For Generic Manufacturers:
    patent landscape mapping aids in identifying potential patent barriers or opportunities for design-around strategies.

  • For Patent Attorneys:
    Detailed claim examination, including infringement analysis, involves scrutinizing claim language and prior art references.


Legal and Commercial Considerations

  • Scope vs. Enforcement:
    Wide claims offer stronger exclusivity but are more susceptible to invalidation. Precise, well-drafted claims balance scope and defensibility.

  • Patent Strategy:
    Filing related patents, including method-of-use or formulation patents, diversifies protection.

  • Regulatory and Market Factors:
    Patent rights in Argentina intersect with regulatory approvals, influencing commercialization timelines.


Conclusion

Patent AR121658’s scope centers on a specific pharmaceutical invention characterized by distinct claims that likely protect a novel compound or process. Its positioning within Argentina’s patent landscape indicates strategic importance, especially if it pertains to a high-value therapeutic area. Stakeholders should continually monitor related filings, patent validity status, and potential challenges to optimize their IP and commercial strategies.


Key Takeaways

  • Scope Definition:
    Clear, well-drafted claims secured AR121658’s core innovation, primarily targeting a specific chemical or manufacturing process.

  • Claims Strategy:
    Independent claims establish broad rights; dependent claims enhance enforceability and manage risk.

  • Landscape Positioning:
    The patent exists within a dynamic Argentine pharmaceutical IP environment, with overlapping rights and ongoing patent filings influencing market exclusivity.

  • Legal Vigilance:
    Regular monitoring for validity challenges or patent expirations is essential to sustain competitive advantage.

  • Strategic Consideration:
    Diversify patent claims (composition, process, use) and consider international filings to expand protection.


FAQs

1. What is the primary novelty claimed in AR121658?
While the specific claims depend on detailed patent documentation, typically, such patents claim a novel chemical structure, improved formulation, or an innovative manufacturing process that distinguishes it from prior art.

2. How does AR121658 compare to international patents?
The patent’s protection in Argentina may differ from international equivalents; examining corresponding filings in key markets like the US, EU, or PCT applications reveals the breadth of global protection and potential licensing opportunities.

3. Can competitors develop similar drugs around AR121658?
Potentially, if they design-around claims by modifying compounds or processes to avoid infringement, especially if the claims are narrow.

4. What are the risks of patent invalidation for AR121658?
Risks include prior art disclosures not considered, insufficient inventive step, or claims found overly broad or indefinite.

5. When will AR121658 expire?
Typically, pharmaceutical patents in Argentina last 20 years from the earliest priority date, though specific expiration depends on filing and priority dates, and any supplementary protection certificates (SPCs) granted afterward.


References

  1. Argentina Patent Office (INPI). Official patent documents and legal status records.
  2. World Intellectual Property Organization (WIPO). Patent landscape reports and PCT filings related to pharmaceutical inventions.
  3. Patent filings and legal analyses accessible through Argentine patent databases and international patent databases such as Espacenet and INPADOC.

This analysis aims to provide a comprehensive understanding of ARG 121658's patent scope, claims, and landscape implications, supporting informed decision-making for stakeholders involved in the Argentine pharmaceutical patent environment.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.